Clinical Trials Browser

Phase 3 × vorasidenib × Lymphoid × Clear all

NCT07215910 2025-10-14

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Phase 3 Not yet recruiting

Astrocytoma, Lymphoma, Follicular